The Europe Syringe Market Report is Segmented by Usability (Sterilizable/Reusable Syringes and Disposable Syringes), Material (Glass and Plastic), by Type (General and Specialized Syringes), Application (Diabetes, Botox, Osteoarthritis, Human Growth Hormone, and Other Applications), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The Report Offers the Value (USD) for the Above Segments.

The East European syringe market was estimated at $10.9B in 2024, remaining constant against the previous year. The total consumption indicated a measured expansion from 2012 to 2024: its value increased at an average annual rate of +3.9% over the last twelve years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2024 figures, consumption decreased by -0.8% against 2022 indices.

Snapshot img

Syringe And Needle Market Size 2024-2028

The syringe and needle market size is forecast to increase by USD 10.96 billion at a CAGR of 8% between 2023 and 2028.

The market encompasses various types of syringes, including ophthalmic, bone marrow, and catheter syringes, which find applications in general surgery, diagnostic, and respiratory applications within the healthcare system. Market growth is driven by the increasing prevalence of critical care conditions and innovations in pre-filled syringes. However, competition from alternative drug delivery systems poses a challenge to market growth. Disposable syringes dominate the market due to their convenience and ease of use, while reusable syringes continue to be used in specific applications, such as orthopedic surgeries. The healthcare products industry is continually evolving, with a focus on improving patient safety and reducing healthcare costs. This market analysis report provides an in-depth examination of these trends and challenges in the market.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market holds a pivotal role in the healthcare industry, particularly in the context of drug delivery technology. This market caters to the requirements of hospitals and healthcare systems for various applications, including pre-filled syringes (PFS) for vaccinations and chronic therapies. Vaccinations are a crucial aspect of preventive healthcare, especially in the face of infectious diseases and long-term conditions such as diabetes, cardiovascular diseases, and cancer. The World Health Organization (WHO) focuses on the importance of vaccines in disease prevention and control and the need for a reliable and efficient market to ensure the availability of vaccine doses. The market also plays a significant role in the delivery of injectable drugs for chronic diseases like diabetes. Moreover, the market caters to the needs of outpatient treatments, ensuring safety and effectiveness in the administration of injectable drugs. The geriatric population, a growing demographic, benefits greatly from these advancements, as they are more susceptible to chronic diseases and long-term therapies. Safety is a primary concern in the market, with a focus on reducing needle stick injuries and minimizing the risk of viral transmission.



This is especially important in the context of hospitals and healthcare facilities, where large volumes of injections are administered daily. The Asia Pacific markets represent a substantial growth opportunity for the market, driven by the increasing prevalence of long-term diseases and the need for injectable development in this region. The market is expected to witness steady growth, fueled by advancements in drug delivery technology and the increasing demand for vaccines and chronic disease management. In conclusion, the market plays a vital role in addressing the vaccination needs and long-term disease management requirements of healthcare systems. Its significance is underscored by the increasing prevalence of chronic diseases and the need for effective and safe drug delivery technology. The market's continued growth is expected to contribute positively to the healthcare industry, ensuring the availability of essential vaccines and injectable drugs for the global population.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Hospitals and clinics
  Home care
  Others


Product

  Syringe
  Needle


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By End-user Insights

The hospitals and clinics segment is estimated to witness significant growth during the forecast period.

In the healthcare sector, syringes and needles, specifically Ophthalmic Syringes, Bone Marrow Syringes, and Catheter Syringes play a significant role in various applications. Hospitals and clinics are the primary consumers of these healthcare products due to their essential use in administering medications, including vaccines, anticoagulants, and biologics. The benefits of using syringes and needles for drug delivery are numerous. They ensure ease of administration, precise dosing, and extended storage time, making them a preferred choice for healthcare professionals. The European Board of Anaesthesiology (EBA), the National Patient Safety Agency, and the Association of Anaesthetists of Great Britain and Ireland advocate for the use of syringes and needles in all possible applications.

Furthermore, disposable syringes and reusable syringes are both widely used in the healthcare sys

The European syringe market, valued at €4.92 billion in 2025, is projected to experience robust growth, driven by factors such as the rising prevalence of chronic diseases necessitating injectable medications (like diabetes and osteoarthritis), increasing demand for advanced drug delivery systems (pre-filled syringes), and stringent regulations promoting patient safety (safety syringes). The market's expansion is further fueled by technological advancements leading to the development of more ergonomic, user-friendly, and efficient syringe designs, catering to both healthcare professionals and home-use applications. The segment of disposable syringes, particularly safety syringes, is expected to dominate due to infection control concerns and the shift away from reusable options. Plastic syringes are gaining traction over glass owing to their cost-effectiveness and ease of disposal, although glass syringes maintain a significant presence in specialized applications requiring higher chemical inertness. Geographically, Germany, the UK, and France are expected to be the largest markets within Europe, reflecting their robust healthcare infrastructures and higher per capita healthcare spending. The market's growth, however, faces challenges such as price pressures from generic manufacturers and the potential for fluctuations in raw material costs. The forecast period (2025-2033) anticipates a consistent CAGR of 7.63%, driven primarily by the aforementioned factors and an expanding elderly population requiring increased medical interventions. The competitive landscape is characterized by both large multinational corporations and specialized manufacturers, with companies like Becton Dickinson, B. Braun, and Terumo holding significant market share. These established players are engaging in strategies including mergers and acquisitions, product innovation, and geographical expansion to strengthen their market positions. Emerging players are focusing on niche segments and developing innovative syringe technologies to compete effectively. The ongoing focus on improving patient safety and reducing healthcare-associated infections is expected to stimulate further demand for advanced syringe features and technologies, such as needle-safety mechanisms and pre-filled syringes. This consistent demand, coupled with favorable market dynamics, indicates a promising outlook for the European syringe market during the forecast period. Recent developments include: April 2023: Delta Med Group and an Italian medical device company, DBM, signed a strategic partnership to strengthen their positioning in the pre-filled syringes market., March 2023: Stevanato Group, an Italian provider of drug containment, drug delivery, and diagnostic solutions, signed a collaboration with Recipharm, a Swedish contract development and manufacturing organization. Under the agreement, Stevanato will support the development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.. Key drivers for this market are: Rising Burden of Chronic Diseases and Infectious Diseases, Increasing Mass Vaccination Programs4.2.3 Trend of Self-Administration of Injections, and Greater Dose Precision in Injections. Potential restraints include: Rising Burden of Chronic Diseases and Infectious Diseases, Increasing Mass Vaccination Programs4.2.3 Trend of Self-Administration of Injections, and Greater Dose Precision in Injections. Notable trends are: The Pre-fillable Syringes Segment is Expected to Witness Significant Growth During the Forecast Period.

The Europe Insulin Syringe Market is Segmented Into Geography (United Kingdom, Germany, France, Russia, Spain, Italy, And the Rest of Europe). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

The Europe anesthesia needles and syringes market is segmented into products, including anesthesia needles, anesthesia syringes, and safety features. Anesthesia needles come in various sizes and gauges to accommodate different types of procedures. Anesthesia syringes are designed to deliver precise doses of anesthesia, and safety features, such as needle retraction systems, minimize the risk of needlestick injuries. Recent developments include: In July 2024, GBUK Group Ltd. acquired Care & Independence (C&I), a rapidly expanding UK-based provider of patient handling and mobility devices. .

The global medical syringes and needles market is booming, projected to reach [estimated 2033 market size] by 2033, driven by rising vaccination rates, chronic disease prevalence, and technological advancements. Explore market trends, key players (BD, B. Braun, Gerresheimer), and regional insights in this comprehensive analysis.

The European market for syringes, with or without needles, is projected to see continued growth over the next decade. Forecasts anticipate a steady increase in market volume and value, with a projected market volume of 45 billion units and a value of $149,905.8 billion by 2035.

Discover the latest market trends in the European Union for syringes, with or without needles. The market is expected to see steady growth in both volume and value terms over the next decade.

The Syringe and Needle Market is Segmented by Product Category (Syringes [Disposable and Reusable] and Needles [Hypodermic and More]), Material (Plastic, Glass, and More), Application (Insulin Administration, Vaccination, and More), End User (Hospitals and Clinics, Ambulatory Surgery Centers, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market and Forecasts are Provided in Terms of Value (USD).

The global disposable syringes and needles market is experiencing robust growth, driven by factors such as the rising prevalence of chronic diseases necessitating frequent injections, increasing surgical procedures, and a growing demand for vaccination programs worldwide. The market is segmented by application (hospitals and clinics, home use, others) and type (conventional, safety, pre-filled, others). Hospitals and clinics currently dominate the application segment due to the high volume of injections administered in healthcare settings. However, the home-use segment is witnessing significant growth fueled by the increasing preference for self-administered medications and the rising prevalence of at-home healthcare. Safety syringes and needles are gaining traction due to their enhanced safety features, reducing the risk of needle-stick injuries for healthcare professionals and patients. The pre-filled syringes segment is also experiencing rapid expansion, owing to their convenience, improved accuracy in dosage administration, and reduced risk of contamination. Major players in the market include BD, Terumo, Nipro, and others, continually innovating to improve product design, safety, and efficiency. Geographical expansion into emerging markets with growing healthcare infrastructure is another key driver of market expansion. While price fluctuations in raw materials and stringent regulatory requirements pose some challenges, the overall market outlook remains positive, projecting a substantial increase in value over the forecast period. The competitive landscape is characterized by the presence of both established multinational corporations and regional players. Established players leverage their extensive distribution networks and brand recognition to maintain a strong market position. However, regional players are gaining traction by offering cost-effective alternatives and catering to specific regional needs. Strategic collaborations, mergers, and acquisitions are common strategies employed to enhance market share and expand product portfolios. Furthermore, continuous technological advancements, including the development of innovative needle designs and advanced materials, are shaping the market trajectory. The focus on improving patient safety and reducing healthcare costs is likely to drive innovation and market expansion in the coming years. Future growth will depend on factors including advancements in injection technology, the efficacy of vaccination campaigns, and the evolving healthcare landscape in both developed and developing economies.

This statistic displays the revenue generated by the syringe and needles market in the European Union * countries in 2007, 2014 and forecast to 2021. The revenue generated by the syringes and needles market is expected to increase to **** billion U.S. dollars in 2021.

Discover the booming syringe needle market! This comprehensive analysis reveals a $513.3M (2025) market with a 5.6% CAGR, driven by rising chronic diseases and advancements in safety syringe technology. Explore regional trends, key players (Becton Dickinson, Terumo, etc.), and future growth projections in this in-depth report.

The European insulin syringe market, valued at €111.88 million in 2025, is projected to grow at a CAGR of 1.20% until 2033. Driven by rising diabetes prevalence and product innovation, the market faces challenges from price sensitivity and competition. Key players include Becton Dickinson and Terumo. Learn more about market trends and forecasts. Recent developments include: November 2023: Terumo India launched new Insulin Syringe for diabetic patients who need daily injections to control their condition., October 2022: Becton, Dickinson, and Company and Biocorp signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies will integrate Biocorp's Injay technology. It is a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes., October 2022: Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and manufacturer of primary container, injection, and infusion therapy devices, launched a ready-to-fill polymer syringe. The PLAJEX 2.25 mL with a tapered needle is specifically designed for challenging biotech products with a larger volume.. Notable trends are: Increasing diabetes prevalence.

Snapshot img

Hypodermic Needles Market Size 2025-2029

The hypodermic needles market size is forecast to increase by USD 2.38 billion, at a CAGR of 8% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing target population requiring injections for various medical treatments and the high demand for vaccines. However, this market faces challenges as alternatives such as needle-free or minimally invasive delivery devices gain traction. These alternatives offer advantages like reduced pain, improved patient compliance, and reduced risk of infection. As the healthcare industry continues to innovate, companies must adapt to these trends and find ways to differentiate their offerings. However, the market faces challenges from the availability of alternatives, such as auto-injectors and insulin pens, which offer convenience and ease of use for patients.
Additionally, partnerships and collaborations with healthcare providers and research institutions can help companies stay informed about the latest medical advancements and patient needs. Navigating the challenges posed by alternatives will require strategic planning and a strong focus on product innovation and patient satisfaction. To capitalize on market opportunities, manufacturers can focus on developing hypodermic needles with enhanced safety features, improved comfort, and cost-effectiveness. Pharmaceutical packaging, medical waste management, and biodegradable needles are also important considerations.

What will be the Size of the Hypodermic Needles Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in patient comfort metrics and technological innovations. Point geometry analysis and needle sharpness testing are critical factors in ensuring optimal needle performance and reducing patient discomfort. Needle bending resistance and lubricant coating types are essential considerations in needle manufacturing processes, impacting needle breakage frequency and syringe needle compatibility. Quality control procedures and needle manufacturing processes have gained significant attention, with insertion force reduction and sheath material selection playing crucial roles in improving user experience. Safety engineered needles and disposable needle features have become increasingly popular, with needle strength testing and needle length selection essential for optimal performance.

Industry growth in the market is expected to reach double-digit percentages in the coming years, driven by the demand for needles with improved needle tip integrity, reduced tissue trauma, and needle material properties that enhance durability. For instance, a leading pharmaceutical company reported a 15% increase in patient satisfaction rates after implementing a new needle design with a reduced bevel angle and improved penetration force measurement. Cannulas with a diameter range of 16 to 25 gauge are gaining popularity due to their ability to minimize tissue trauma and improve needle resilience analysis. Needle clogging prevention and sterilization techniques are also essential aspects of needle manufacturing, with hub design variations and syringe compatibility playing a significant role in ensuring efficient needle usage.

Injection technique effects, durability assessment, coring phenomenon analysis, and needle gauge sizes are other critical factors influencing market trends. Material biocompatibility and needle tip integrity are essential for minimizing adverse reactions and ensuring optimal patient outcomes. Overall, the market continues to unfold with ongoing innovation and evolving patterns, driven by the need for improved patient comfort, safety, and efficiency. Regulatory compliance, such as FDA regulations and CE marking, plays a crucial role in ensuring the safety and efficacy of hypodermic needles in various applications, including blood collection, injection therapy, and hospital supplies.

How is this Hypodermic Needles Industry segmented?

The hypodermic needles industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Safety needles
  Non-safety needles


End-user

  Hospitals and clinics
  ASCs
  Others


Application

  Drug delivery
  Vaccination
  Blood specimen collection


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By Product Insights

The Safety needles segment is estimated to witness significant growth during the forecast perio

Analysis of Europe's syringe market, including consumption, production, import, and export trends from 2013-2024, with forecasts to 2035. Covers market value, volume, key countries, and trade dynamics.

Explore the dynamic medical syringes and needles market trends, forecasts, and growth drivers reaching $7,931 million by 2025 with a 3.1% CAGR. Discover key segments, leading companies, and regional insights.

The Europe Dental Cartridge Syringe Market would witness market growth of 4.5% CAGR during the forecast period (2024-2031). In the year 2021, the Europe market's volume surged to 1,606.9 thousand units, showcasing a growth of 15.5% (2020-2023). In the Market, disposable dental syringes emerge as i

The size of the Insulin Syringe Market in Europe market was valued at USD 111.88 Million in 2023 and is projected to reach USD 121.62 Million by 2032, with an expected CAGR of 1.20% during the forecast period. Recent developments include: November 2023: Terumo India launched new Insulin Syringe for diabetic patients who need daily injections to control their condition., October 2022: Becton, Dickinson, and Company and Biocorp signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies will integrate Biocorp's Injay technology. It is a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes., October 2022: Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and manufacturer of primary container, injection, and infusion therapy devices, launched a ready-to-fill polymer syringe. The PLAJEX 2.25 mL with a tapered needle is specifically designed for challenging biotech products with a larger volume.. Key drivers for this market are: Increase in Burden of Chronic Diseases, Growing Biotech Industry and Research in Cell Biology. Potential restraints include: High Cost of Cell Analysis, Complex Regulatory Scenario. Notable trends are: Increasing diabetes prevalence.

The global syringe needle market is booming, projected to reach $1.25 billion by 2033 with a 5.5% CAGR. Driven by rising chronic diseases and surgical procedures, this market analysis explores key trends, restraints, and regional growth in North America, Europe, and Asia-Pacific. Learn more about leading companies and market segmentation.